Jul
02
2007

Cervarix, another vaccine for cervical cancer

Cervarix, a second vaccine for cervical cancer prevention.

Cervarix vaccine: competition for Gardasil
Cervarix vaccine: competition for Gardasil

Results of the new vaccine, Cervarix, were recently published in Lancet. Report co-author Dr Rachel Skinner said the results were very encouraging.

"We have found through this study that this vaccine is extremely effective in the prevention of pre-cancerous disease of the cervix due to infection with HPV types 16 and 18."
"However we now have evidence that Cervarix offers women broader protection by providing some protection against infections caused by HPV types 45 and 31. These types together with HPV types 16 and 18 account for 80 per cent of cases of cervical cancer worldwide.

Nearly 500,000 new cervical cancer victims each year.

Cervical cancer is a major global health problem, with nearly 500,000 new cases occurring each year worldwide. It is the second most common cancer - and the third leading cause of cancer deaths - in women worldwide. Each year an estimated 270,000 women die from the disease, and it is the leading cancer killer of women in the developing world.

Links to our ongoing discussions on cervical cancer vaccinations.

Source article: GlaxcoSmithKline

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <a> <h3> <h4> <em> <i> <strong> <b> <span> <ul> <ol> <li> <blockquote> <object> <embed> <param> <sub> <sup>
  • Lines and paragraphs break automatically.
  • You may embed videos from the following providers vimeo, youtube. Just add the video URL to your textarea in the place where you would like the video to appear, i.e. http://www.youtube.com/watch?v=pw0jmvdh.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Images can be added to this post.

More information about formatting options